Biotech6 years ago
Bristol-Myers, Celgene merger to lead cancer treatment market in 2019
With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...